https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/ABCNEWS.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-18 10:55:072021-08-21 11:00:11Biden administration to begin rolling out booster shots the week of Sept. 20
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-18 10:49:582021-08-21 10:51:30What to Know About Boosters if You Got the Johnson & Johnson Vaccine
The decision to expand the emergency use of both the Pfizer-BioNTech and Moderna vaccines is meant to help transplant recipients and others whose immune systems are similarly compromised. Read Article […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-14 08:23:242021-08-16 08:25:46F.D.A. to Authorize Third Vaccine Dose for People With Weak Immune Systems
Dan Barouch, Harvard Medical School professor and head of Beth Israel Deaconess’ Center for Virology and Vaccine Research, was awarded Harvard’s George Ledlie Prize for his work on one of […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/harvard-gazette.jpg275281Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-09 14:38:152021-08-09 14:38:15Dan Barouch and the birth of the J&J COVID vaccine
“This study was conducted as a real-world efficacy study in one of the most challenging epidemiologic settings,” said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/05/nyt.png400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-06 09:32:512021-08-09 09:33:58New data suggest J. & J. vaccine works against Delta and recipients don’t need a booster shot.
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/10/wsj.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-08-06 09:30:142021-08-09 09:31:11J&J Vaccine Highly Effective Against Delta Variant in South African Trial
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/09/AA0O_yzc_400x400.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-07-21 09:27:142021-07-22 09:38:03We’re Zeroing In On the ‘Holy Grail’ of COVID-19 Immunity
Dan Barouch, told ABC News in late May that the pharmaceutical companies have an economic incentive and that a decision on booster shots should be made based on public health […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2020/04/ABCNEWS.jpg400400Morgana Souzahttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngMorgana Souza2021-07-08 13:33:492021-07-09 13:35:32Study shows booster shot after 6 to 12 months likely to provide best protection from COVID-19, Pfizer says
J&J Says Covid-19 Vaccine Booster Two Months After First Shot Increases Protection
/in NewsTrial participants in the U.S. who received a second dose eight weeks after the first had 94% protection against the illness. Read Article
2nd dose of J&J COVID-19 vaccine results in stronger protection, company says
/in NewsThe shots, given two months apart, can offer 94% protection against infections. Read Article
Biden administration to begin rolling out booster shots the week of Sept. 20
/in NewsHealth care workers and nursing home residents are first in line Read Article
What to Know About Boosters if You Got the Johnson & Johnson Vaccine
/in NewsHealth experts say that boosters are likely to be needed eventually and that more data should be available in the next several weeks. Read Article
F.D.A. to Authorize Third Vaccine Dose for People With Weak Immune Systems
/in NewsThe decision to expand the emergency use of both the Pfizer-BioNTech and Moderna vaccines is meant to help transplant recipients and others whose immune systems are similarly compromised. Read Article […]
Dan Barouch and the birth of the J&J COVID vaccine
/in NewsDan Barouch, Harvard Medical School professor and head of Beth Israel Deaconess’ Center for Virology and Vaccine Research, was awarded Harvard’s George Ledlie Prize for his work on one of […]
New data suggest J. & J. vaccine works against Delta and recipients don’t need a booster shot.
/in News“This study was conducted as a real-world efficacy study in one of the most challenging epidemiologic settings,” said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in […]
J&J Vaccine Highly Effective Against Delta Variant in South African Trial
/in NewsStudy finds J&J vaccine has an efficacy of up to 71% against hospitalization from the highly contagious strain. Read Article
We’re Zeroing In On the ‘Holy Grail’ of COVID-19 Immunity
/in News“The more breakthroughs you have, the easier it is to determine,” Katy Stephenson. Read Article
Study shows booster shot after 6 to 12 months likely to provide best protection from COVID-19, Pfizer says
/in NewsDan Barouch, told ABC News in late May that the pharmaceutical companies have an economic incentive and that a decision on booster shots should be made based on public health […]